DelMar Pharmaceuticals Named to the “Ready to Rocket” List for the Second Year in a Row February 28, 2012 • 12:00 AM EST
DelMar Pharmaceuticals to Present New Pre-clinical Data Related to the Mechanism of VAL-083 at the AACR Annual Meeting in April 2012 February 7, 2012 • 12:00 AM EST
DelMar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of Glioma February 2, 2012 • 12:00 AM EST
DelMar Pharmaceuticals Receives FDA IND Approval to Begin Clinical Trials with a New Brain Cancer Treatment September 6, 2011 • 12:00 AM EDT
DelMar Pharmaceuticals Selected to Present at 10th Annual BIO Investor Forum August 16, 2011 • 12:00 AM EDT
DelMar Pharma Receives Funding Support from National Research Council of Canada August 2, 2011 • 12:00 AM EDT
DelMar Pharma Invited to Present at Leading Life Sciences Conference February 18, 2011 • 12:00 AM EST